Growth Company Research Results 2024


In this research, conducted at our Growth Company Retreat, we asked leaders of high and fast-growth businesses about the challenges and opportunities they face this year, as well as their most likely exit routes.

Key findings from Criticaleye's Growth Company Research:

  • 61% expect to conduct M&A in the next 12 months
  • Only 25% says their management team can navigate strategic uncertainty
  • Improved business performance is the top priority for leaders
  • 88% say their Boards are aligned on strategy
  • A trade exit is the most likely route for growth businesses
  • Internal silos are the biggest barrier to building a customer-centric culture


In a recent Inspiring Leaders podcast, we spoke to growth company leaders about priorities for the next 12 months, advice for first-time CEOs and how the Chair can support their CEO. Click here to listen to this episode featuring special guests Brittany Harris, Co-founder and CEO, Qualis Flow, Mark Whitby, Chair, BibliU and Board Mentor, Criticaleye and Melanie Lane, CEO, Pod Point.

Share this with your Community




Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

BLOG | What Sets World-Class CEOs Apart in Uncertain Times?

If you're a CEO today, you’re likely feeling the pressure to be a technologist, a geopolitical expert and a visionary all at once. Markets are shifting rapidly, the operating...


Click here to download this insight

Health and Wellbeing at Work

The CIPD’s 2025 Health and Wellbeing at Work report, supported by Criticaleye CPO Retreat 2026 Partner Simplyhealth, examines health, wellbeing and attendance trends and challenges. Now in its 24th edition, t...


Inspiring Leaders Podcast: Sally Bridgeland, Chair, Development Bank of Wales and Keith Cochrane, Chair, Schenck Process Group, on Risk in the Boardroom

In this episode, Sally Bridgeland, Chair, Development Bank of Wales, Nest Invest and BelleVie Care and Keith Cochrane, Chair, Schenck Process Group talk about what risks will be on the Board agenda this yea...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 238




Aldermore Group AlixPartners Lightsource bp Canaccord Genuity Group Inc Legal & General Mayborn Group British Land Rolls-Royce NATS London Stock Exchange Group Drax Group plc LACE Partners NatWest Group GlaxoSmithKline plc E.ON UK Hitachi Solutions Worldpay